Infectious Disease Flashcards
Tx of echinococcus
albendazole
Tx of strongyloides
ivermectin
___ is associated with increased risk of invasive pneumococcal PNA
opioid use
___ (behavior) is associated with increased CAP
high alcohol consumption
risk factors for pseudomonas pna
- prior pseudomonas infection
- bronchiectasis
- tracheostomy
- COPD
WHich imaging has highest sensitivity of PNA
POCUS
CT Chest
Most common pathogens in lower respiratory infection
VIRUSES - more common than bacterial
#1 rhinovirus
Influenza A & B
HMP
RSV
Parainfluenza
Coronavirus
Adenovirus
and #1 strep pneumoniae
MRSA nares has what components of the following (high or low)
Sensitivity
Specificity
PPV
NPV
85% sensitivity
92% specificity
POOR PPV (57%)
great NPV (98%)
If the test is negative, very unlikely that MRSA is present in the lungs
Parente, Clin ID 2018
Does having MRSA in the past 12 mo show colonization?
no
In non-severe outpatient CAP, what testing is indicated
Influenza
Covid
In severe and non-severe admitted patients with CAP, what testing is indicated
What about immunocompromised patients
(Based on ATS/IDSA 2019 guidelines)
Influenza
Blood & resp culture (only if risk of MRSA or pseudomonas in non-severe)
Legionella U Ag only if local outbreak
MRSA PCR
In severe CAP and immunocompromised, additionally should include legionella UAg no matter what, Strep urinary Ag
PNA PCR (NAAT)
RVP
What is the effect of using procalcitonin in treatment of CAP
reduce the # of days the patient will be on Abx
CURB 65
Confusion
Urea
Resp
Blood pressure <90/60
> 65 yo
3 or more requires hospitalization
Severe CAP criteria (whether or not to admit to ICU)
Either 1 major or 3+ minor
Major criteria:
1. Septic Shock with need of vasopressors
2. Respiratory failure requiring mechanical ventilation
Minor:
- RR >30bpm
- P:F ratio <250
- Multilobar infiltrates
- Confusion
- Uremia BUN >20
- Leukopenia <4000
- Thombocytopenia <100
- Hypothermia core <36C
- Hypotension requiring aggressive fluid resus
Minor: RPM CULTHH
CAP outpatient tx
No comorbidities:
the usuals (amox, doxy, or macrolides)
+ comorbidities:
Augmentin
Cefuroxime
PLUS macrolide or doxy
or resp fluoroquinolone
ATS/IDSA 2019
CAP inpatient tx
Non-severe:
beta-lactam + macrolide
OR
resp fluoroquinolone
+ antipseudomonal if prior pseudomonas in 12 mo
Severe:
betalactam + macrolide
OR
betalactam + resp fluoroquinolone
for either above:
+ Anti-MRSA to be added if prior MRSA infection in 12 mo
+ anti-pseudomonal if prior pseudomonas in 12 mo
Covid tx outpatient
paxlovid
can get remdesivir
Indication for starting remdesivir for covid 19
hospitalization
O2 requirement (but not if its so severe you need HFNC, can consider in those who are at high risk of dz progression)
Indication for starting dexamethasone in covid 19
requiring O2 supplement
If with HFNC, should be given with remdesivir
If still very hypoxic, add baricitinib or IV tocilizumab
Indication for giving IV tocilizumab in covid-19 infection
(or IV sarilumab)
Hospitalized, requiring mechanical ventilation or ECMO
within 24h of MICU admission
When is remdesivir NOT indicated for covid-19 infection
hospitalized without O2 requirement OR mechanically ventilated OR ECMO
(so the mild-moderate people can get it, not the severe)
Duration of abx for CAP coverage in the hospital
3-5-7days if clinically stable
When should you cover for anaerobes in PNA
severe CAP (even this is controversial)
Parapneumonic effusion
WHen is corticosteroids indicated in CAP
severe CAP with high CRP
Covid-19 with O2 requirement
Contraindicated in influenza
Vaccinations indicated for respiratory protection (6)
Influenza
Covid-19
RSV
PCV20
Herpes Zoster
TdaPertussis
Definition of HAP
> 48h in the hospital
Ventilator associated pneumonia definition
ventilated for >48h
AND
2 or more of:
fever
abnormal WBC
sputum purulence
New infiltrate
VAP after vomiting in a patient who had abd surgery, patient likely has which pathogen
pseudomonas aeruginosa!
Gram negative bacteria
Rate of anaerobes in VAP and aspiration pneumonia
pretty much none
Superinfections in the ICU associated with covid-19 include which pathogens?
(4 bacteria, 2 fungi)
acinetobacter
e. coli
kleb
pseudomonas
candida
aspergillus
MDR risk factors (3)
- IV abx in the past 90 days
- Unit rate >20% of MRSA
- positive screening or prior infection or colonization with MDR
Most relevant risk factor for suspecting MDR pathogens in patients with HAP
prior IV Abx use within 90 days
HAP tx (no MDR risk factors with low risk of death)
zosyn
cefepime
levoflox
imipenem or meropenem
consider coverage for MSSA
If CF or NonCF bronchiectasis, consider pseudomonal coverage
VAP tx
MRSA coverage
Pseudomonal coverage (consider double)
Risk factor for MRSA
Prior 90d abx therapy
Unit rate 10-20% prevalence or unknown
Need for vent support or septic shock
When to add double pseudomonal coverage in HAP
High mortality risk
VAP
prior risk of pseudomonas
What abx should you not use alone for HAP
aminoglycoside
Duration of tx for HAP or VAP
7d
unless non-lactose fermenting GNR (pseudomonas, acinetobacter, steno) and not getting better, consider longer duration
Tx for acinetobacter HAP/VAP sensitive only to polymyxins
IV polymyxin (colistin or polymyxin B)
AND
adjunctive inhaled colistin
No effect on mortality or nephrotoxicity but with clinical improvement
For GNR/acinetobacter VAP/HAP with sensitivity to aminoglycosides or polymyxins OR carbapenem resistant, must use ____
both inhaled and systemic abx
Should you treat ventilator associated tracheitis?
NO
Tx of acinetobacter and pseudomonas (at the same time)
cefiderecol
Treatment of acinetobacter
unasyn (beta lactams)
or carbapenems and fluoroquinolones
aminoglycoside or bactrim for UTI
Resistant disease: polymyxin B, colistin
Carbapenemase producing genes (Enterobacterales)
KPC
OXA-48
MBL
Most common resistance mechanism in pseudomonas (intrinsic)
DNA gyrase and topoisomerase IV (fluoroquinolone resistance)
AmpC (b-lactams)
Most common resistance mechanism in pseudomonas (imported)
class A, B, D ….
b-lactam (ESBL) and carbapenem resistance and abx inactivation
Important VAP prevention
Oral care- toothbrushing WITHOUT chlorhexedine
Minimize sedation
Maintain and improve physical conditioning
Avoid intubation/prevent reintubation
What ICU interventions have no impact on VAP rates
stress ulcer ppx
monitoring residual gastric volumes
closed endotracheal suctioning systems
percent of household contact that will become infected with TB
~35%
Percent of LTBI that progresses to TB disease
how about if you’re on HIV or TNF alpha-blockers?
~10% per lifetime
HIV and TNF alpha blocker = 10% PER YEAR
MDR TB definition
Resistant to INH AND Rifampin
XDR TB definition
MDR TB (INH, Rif) +
Fluoroquinolone
AND
at least one of the injectables or bedaquiline/linezolid
infecting dose of MTB = __#___ organisms
10
smear negative TB but culture positive, how infectious is the patient?
15-17%
Most common location of pulmonary TB in immunocompetent patient
RUL posterior segment
Sensitivity of 3x AFB and 2x MTB PCR for TB disease
85%
Pregnant patients and TB tx
IRE (no PZA - in US lack of safety data, though WHO recommends it)
for 2 mo, then 7 mo of IR (total 9 mo)